N-acentylcysteine, a thiol antioxidant, decreases alveolar bone loss in experimental periodontitis in rats

Journal of Periodontology

Volumn 80, Issue 4, 2009, Pages 672-678

  Tokar, Hulya ^a   Ozdemir, Hakan ^a   Eren, Kaya ^b   Ozer, Hatlce ^a   Sahm, Gonul ^c  

^a CUMHURIYET UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Alveolar bone loss; Antioxidant; Ligature; N acetylcysteine; Periodontitis

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; MALE; OSTEOCLAST; OSTEOLYSIS; PERIODONTITIS; RAT; WISTAR RAT;

ACETYLCYSTEINE; ALVEOLAR BONE LOSS; ANIMALS; ANTIOXIDANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; OSTEOCLASTS; PERIODONTITIS; RATS; RATS, WISTAR;

EID: 63849342012     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.080509     Document Type: Article

References (45)

1. Albandar JM, Epidemiology and risk factors of periodontal diseases. Dent Clin North Am 2005;49:517-532.
2. Hasturk H, Kantarci A, Ebrahimi N, et al. Topical H2 antagonist prevents periodontitis in a rabbit model. Infect Immun 2006;74:2402-2414.
3. Schwartz Z, Goultschin J, Dean DD, Boyan BD. Mechanisms of alveolar bone destruction in periodontitis. Periodontal 2000 1997;14:158-172.
4. Taubman MA, Kawai T. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit Rea Oral Biol Med 2001;12:125-135.
5. Chappie IL, Brock G, Eftimiadi C, Matthews JB. Glutathione in gingival crevicuiar fluid and its relation to local antioxidant capacity in periodontal health and disease. J Clin Pathol 2002;55:367-373.
6. Chappie IL, Brock GR, Milward MR, Ling N, Matthews JB. Compromised GCF total antioxidant capacity in periodontitis: Cause or effect? J Clin Periodontol 2007: 34:103-110.
7. Buduneii N, Kardeşler L, Işik H, et al. Effects of smoking and gingival inflammation on salivary antioxidant capacity. J Clin Periodontol 2006;33:159-164.
8. Harrison D, Griendling KK, Landmesser 0, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 2003;91:7A-11A.
9. Dandona P, Thusu K, Cook S, et al. Oxidative damage to DNA in diabetes mellitus. Lancet 1996;347:444-445.
10. Konopka T, Krol K, Kopec W, Gerber H. Total antioxidant status and 8-hydroxy-2'-deoxyguanosine levels in gingival and peripheral blood of periodontitis patients. Arch Immunol TherExp (Warsz) 2007;55:417-422.
11. McCord JM. Free radicals and inflammation: Protection of synovial fluid by superoxide dismutase. Science 1974;185:529-531.
12. Chappie IL. Reactive oxygen species and antioxidants in inflammatory diseases. J Clin Periodontol 1997;24: 287-296.
13. Sakallioglu 0, Aliyev E, Eren Z, Akşimşek G, Keskiner I, Yavuz U. Reactive oxygen species scavenging activity during periodontal mucoperiosteal healing: An experimental study in dogs. Arch Oral Biol 2005;50: 1040-1048,
14. Gokcimen A, Cim A, Tola HT, et al. Protective effect of N-aeetylcysteine, caffeic acid and vitamin E on doxorubicin hepatoxicity. Hum Exp Taxico/2007;26:519-525.
15. Kaplan M, Atakan IF, Aydoǧdu N, et al. Influence of N-acetylcysteine on renal toxicity of cadmium in rats. Pediatr Nephrol 2008;23:233-241.
16. Ross D. Glutathione, free radicals and chemothera-peutic agents. Pharmacol Ther 1988;37:231-249.
17. Zafarullah M, Li WQ, Slyvester J, Ahmad M. Molecular mechanism of N-acetylcysteine actions. Cell Mol Life Sci 2003;60:6-20.
18. Vercelino R, Tieppo J, Simoes Dias A, et al. N-acetylcysteine effects on genotoxic and oxidative stress parameters in cirrhotic rats with hepatopulmonary syndrome. Basic Clin Pharmacol Toxicol 2008; 102:370-376.
19. Balansky RB, D'Agostini F, Zanacchi P, De Flora S. Protection by N-acetylcysteine of the histopathological and cytogenetic al damage produced by exposure of rats to cigarette smoke. Cancer Lett 1992;64:123-131.
20. Muldoon LL, Pagel MA, Kroll RA, et al. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity. Clin Cancer Res 2000;6:309-315.
21. Dickey DT, Muldoon LL, Doolittle ND, Peterson DR, Kraemer DF, Neuwelt EA, Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models. Cancer Chemother Pharmacol 2008:62:235-241.
22. Hsu HY, Wen MH. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J Biol Chem 2002;277:22131-22139.
23. Kim do Y, Jun JH, Lee HL, Woo KM, Ryoo HM, Kim G-S. N-acetylcysteine prevents LPS-induced proinflammatory cytokines and MMP-2 production in gingival fibroblasts. Arch Pharm Res 2007;30:1283-1292.
24. Lee NK, Choi YG, Baik JY, et al. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation, Blood 2005;106:852-859.
25. Kaynak D, Meffert R, Günhan M, Günhan O, Ozkaya O. A histopathological investigation on the effects of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the mandible of rats. J Periodontol 2000;71:790-796.
26. Buduneli E, Vardar S, Buduneli N, et al. Effects of combined systemic administration of low-dose doxy-cycline and alendronate on endotoxin-induced periodontitis in rats. J Periodontol 2004;75:1516-1523.
27. Lima V, Bezerra MM, Alencar VBM, Vidal FDP, Rocha FAC, Brito GAC. Effects of chlorpromazine on alveolar bone loss in experimental periodontal disease in rats. Eur J Oral Sci 2000;108:123-129.
28. Robinson M, Hart D, Pigott GH. The effects of diet on the incidence of periodontitis in rats. Lab Arum 1991; 25:247-253.
29. Sallay K, Sanavi F, Ring I, Pham P, Behling OH, Nowotny A. Alveolar bone destruction in the immunosuppressed rat. J Periodontal Res 1982;17:263-274.
30. Holzhausen M, Spolidorio DMP, Muscara MN, Hebling J, Spolidorio LC. Protective effects of etoricoxib, a selective inhibitor of cyclooxygenase-2, in experimental periodontitis in rats. J Periodontal Res 2005;40:208-211.
31. Di Paola R, Mazzon E, Zito D, et al. Effects of Tempol, a membrane-permeable radical scavenger, in a rodent model of periodontitis. J Clin Periodontol 2005;32: 1062-1068.
32. Xu Y, Wei W. A comparative study of systemic subantimicrobial and topical treatment of minocycline in experimental periodontitis of rats. Arch Oral Biol 2008;51:794-803.
33. Jansson AH, Eriksson C, Wang X. Effects of budesonide and N-acetylcysteine on acute lung hyperinflation, inflammation and injury in rats. Vascul Pharmacol 2005; 43:101-111.
34. Tsuji F, Miyake Y, Aono H, Kawashima Y, Mita S. Effects of bucillamine and N-acetyl-L-cysteine on cytokine production and collagen-induced arthritis (CIA). Clin Exp Immunol 1999;115:26-31.
35. Ancha HR, Kurella RR, McKimmey CC, Lightfoot S, Harty RF. Effects of N-acetylcysteine plus mesalamine on prostaglandin synthesis and nitric oxide generation in TNBS-induced colitis in rats. Dig Dis Sci 2008 Aug 21. [Epub ahead of print],
36. Blackwell TS, Blackwell TR, Holden EP, Christman BW, Christman JW. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. J Immunol 1996; 157:1630-1637.
37. Rocksén D, Lilliehook B, Larsson R, Johansson T, Bucht A. Differential anti-inflammatory and anti-oxi-dative effects of dexamethasone and N-acetylcysteine in endotoxin-induced lung inflammation. Clin Exp Immunol 2000;122:249-256.
38. Sadowska AM, Verbraecken J, Darquennes K, De Backer WA, Role of N-acetylcysteine in the management of COPD. Int J Chron Obstruct Pulmon Dis 2006;1:425-434.
39. Badawy AH, Abdel Aal SF, Samour SA. Liver injury associated with N-acetylcysteine administration. J Egypt Soc Parasitol 1989;19:563-571.
40. Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. N-acetylcysteine - A safe antidote for cysteine/ glutathione deficiency. Curr Opin Pharmacol 2007;7: 355-359.
41. Hall TJ, Schaeblun M, Jeker H, Fuller K, Chambers TJ. The role of oxygen intermediates in osteoclastic bone resorption. Biochem Biophys Res Commun 1995;207:280-287.
42. Lean JM, Davies JT, Fuller K, et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 2003; 112:915-923.
43. Mody N, Parhami F, Sarafian TA, Demer LL. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 2001 ;31:509-519.
44. Jun JH, Lee SH, Kwak HB, et al. N-acetylcysteine stimulates osteoblastic differentiation of mouse cal-varial cells. J Cell Biochem 2008;103:1246-1255.
45. Origuchi T, Migita K, Nakashima T, et al. Regulation of cyclooxygenase -2 expression in human osteoblastic cells by N-acetylcysteine. J Lab Clin Med 2000; 136: 390-394.